Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma, IDH-Wildtype”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Testing effectiveness (Phase 2)Ended earlyNCT00574964
What this trial is testing

Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme

Who this might be right for
Primary Glioblastoma Multiforme
University of Iowa 50
Early research (Phase 1)Looking for participantsNCT07223034
What this trial is testing

177Lu-PSMA-617 in People With Gliomas

Who this might be right for
GliomaDiffuse Astrocytoma, IDH-Wildtype (Grade 2-4)Glioblastoma, IDH-wildtype+3 more
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Not applicableStudy completedNCT05759195
What this trial is testing

Biomolecular Analysis for Predicting Response to Regorafenib

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 53
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Testing effectiveness (Phase 2)Study completedNCT00179907
What this trial is testing

A Phase I/II Study of the Photon Radiosurgery System

Who this might be right for
Brain Tumor, RecurrentGlioblastoma Multiforme
Ann & Robert H Lurie Children's Hospital of Chicago 35
Very early researchEnrolling By InvitationNCT07520214
What this trial is testing

Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeGlioblastom WHO Grade 4
Beijing Neurosurgical Institute 9
Not applicableStudy completedNCT05229198
What this trial is testing

ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas

Who this might be right for
Astrocytoma, Grade IV
Juan M Garcia-Gomez 300
Not applicableNot Yet RecruitingNCT06368934
What this trial is testing

Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma

Who this might be right for
GliomaGlioblastoma
Huashan Hospital 326
Not applicableLooking for participantsNCT06146738
What this trial is testing

The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+1 more
Jasper Gerritsen 1,015
Testing effectiveness (Phase 2)UnknownNCT00311857
What this trial is testing

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Who this might be right for
Glioblastoma Multiforme
Heidelberg University 46
Very early researchLooking for participantsNCT06552260
What this trial is testing

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Ugonma Chukwueke 27
Testing effectiveness (Phase 2)UnknownNCT04614493
What this trial is testing

Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

Who this might be right for
Initial Radiological Diagnosis Eligible for Tumor ResectionInitial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
Assistance Publique - Hôpitaux de Paris 66
Large-scale testing (Phase 3)Looking for participantsNCT06419946
What this trial is testing

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Vastra Gotaland Region 200
Not applicableLooking for participantsNCT06146725
What this trial is testing

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma Multiforme+2 more
Jasper Gerritsen 564
Early research (Phase 1)Looking for participantsNCT06418113
What this trial is testing

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+2 more
Hospital San Carlos, Madrid 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05318612
What this trial is testing

Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)

Who this might be right for
Primary Glioblastoma
Radboud University Medical Center 238
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Large-scale testing (Phase 3)Active Not RecruitingNCT04250922
What this trial is testing

LAM561 With RT and TMZ for Adults With Glioblastoma

Who this might be right for
Primary GlioblastomaGlioblastoma Multiforme
Laminar Pharmaceuticals 144
Load More Results